Safety of a Single Dose of 5 mg of hLF1-11 Given to Autologous Haematopoietic Stem Cell Transplant Recipients

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

November 30, 2006

Study Completion Date

November 30, 2006

Conditions

Hematopoietic Stem Cell TransplantationBacterial Infections and Mycoses

Interventions

DRUG

human lactoferrin peptide 1-11

Each subject will receive a single intravenous dose of hLF1-11 given in a volume of 20mL given over 20 minutes i.e. 1mL/per minute.

Trial Locations (1)

UMC St. Radboud, Nijmegen